AtriCure Inc. (ATRC) PT Raised to $26 at Needham & Company
Needham & Company raised its price target on AtriCure Inc. (NASDAQ: ATRC) to $26.00 (from $23.00) while maintaining a Buy ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
